[Hyperventilation to avoid disturbances of hepatic excretory function in the initial stage of nitrostigmine (E 605 forte) poisoning in rats)].
D000142:Acidosis, Respiratory / Q000150:complications; D000818:Animals; D001646:Bile / Q000187:drug effects / Q000378:metabolism; D001663:Bilirubin / Q000097:blood / Q000378:metabolism; D002800:Cholinesterase Inhibitors / Q000009:adverse effects; D005260:Female; D006863:Hydrogen-Ion Concentration; D000860:Hypoxia / Q000150:complications; D008099:Liver / Q000187:drug effects / Q000503:physiopathology; D008107:Liver Diseases / Q000209:etiology; D010100:Oxygen / Q000097:blood; D010278:Parathion / Q000506:poisoning*; D011041:Poisoning / Q000628:therapy; D051381:Rats; D012121:Respiration, Artificial
D002800:Cholinesterase Inhibitors; D010278:Parathion; D001663:Bilirubin; D010100:Oxygen
Hyperventilation zur Vermeidung von Störungen der exkretorischen Leberfunktion im Initialstadium der Nitrostigmin- (E 605 forte) Vergiftung an Ratten.